Roflumilast Prescribing at STANLEY MEDICAL GROUP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
58
Total Quantity
597
NHS Cost
£719
vs National Avg
+341.8%
STANLEY MEDICAL GROUP prescribed 58 items of Roflumilast over the last 12 months at a cost of £719 to the NHS. This is 341.8% above the national average prescribing rate. Roflumilast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
3
Jul 2026
2
Jul 2026
9
Jul 2026
5
Jul 2026
5
Jul 2026
5
Jul 2026
4
Jul 2026
4
Jul 2026
4
Jul 2026
8
Jul 2026
4
Jul 2026
5
Prescribing Details
| Total Items | 58 |
|---|---|
| Total Quantity | 597 |
| Total NHS Cost | £719 |
| Presentations | 2 different forms |
| vs National Average | +341.8% |
Roflumilast Prescribing Comparison
| This practice | 58 items |
|---|---|
| National average per practice | 13 items |
| Difference | +341.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.